Mengying Wei
Mengying Wei has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Guodong Yang
Department of Biochemistry and Molecular Biology, the Fourth Military Medical University, Xi'an, China
4 shared publications Yan Dong
State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Shaanxi Key Laboratory of Stomatology, Department of Prosthodontics, School of Stomatology
3 shared publications- Lijun Yuan
Department of Ultrasound Diagnostics, Tangdu Hospital, Fourth Military Medical University, Xi’an, China
2 shared publications - Zhelong Li
Department of Ultrasound Diagnostics, Tangdu Hospital, Fourth Military Medical University, Xi'an, China
2 shared publications Zhuo Wan
Department of Hematology, Tangdu Hospital, Fourth Military Medical University, Xi’an 710032, Shaanxi, China
2 shared publicationsGuangsheng Wu
Department of Stomatology, Qingdao Special Servicemen Recuperation Center of PLA Navy, No. 18 Yueyang Road, Qingdao 266071, China
1 shared publication
Latest Publications
- 10 July 2026
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 18 (28) , 38566-38583
EV-Functionalized Fish Scale Scaffold Leverages Topographic and Biochemical Cues for Enhanced Bone Regeneration
The repair of critical-size bone defects remains clinically challenging, largely owing to the limited homing and osteogenic capacity of endogenous bone marrow mesenchymal stem cells (BMSCs). To address this, we developed a cell-free strategy that combines a decellularized fish scale (DC-FS) scaffold with stem cell sheet-derived extracellular vesicles (CS-EVs). This design leverages the scale's innate microgrooved topography for directional cell guidance while loading CS-EVs to provide sustained pro-osteogenic cues. The resulting CS-EVs/DC-FS composite retained the intrinsic micro/nanoarchitecture and mineralized composition of the biological scaffold and permitted controlled EVs release. The scaffold promoted directional migration, adhesion, and osteogenic differentiation of BMSCs in vitro, upregulating key markers including RUNX2, OPN, and BMP2. Mechanistically, EV-derived miRNAs, notably miR-146a-5p, were associated with activation of the Sirt1/Wnt/β-catenin signaling pathway. In a rat critical-size calvarial defect model, CS-EVs/DC-FS accelerated bone deposition, improved trabecular microstructure, and enhanced overall regeneration quality. This study establishes a topography-guided and EV-mediated strategy for bone regeneration, offering an integrated nature-derived solution for reconstructing challenging maxillofacial and orthopedic bone defects.
- 10 July 2026
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 18 (28) , 38566-38583
EV-Functionalized Fish Scale Scaffold Leverages Topographic and Biochemical Cues for Enhanced Bone Regeneration
The repair of critical-size bone defects remains clinically challenging, largely owing to the limited homing and osteogenic capacity of endogenous bone marrow mesenchymal stem cells (BMSCs). To address this, we developed a cell-free strategy that combines a decellularized fish scale (DC-FS) scaffold with stem cell sheet-derived extracellular vesicles (CS-EVs). This design leverages the scale's innate microgrooved topography for directional cell guidance while loading CS-EVs to provide sustained pro-osteogenic cues. The resulting CS-EVs/DC-FS composite retained the intrinsic micro/nanoarchitecture and mineralized composition of the biological scaffold and permitted controlled EVs release. The scaffold promoted directional migration, adhesion, and osteogenic differentiation of BMSCs in vitro, upregulating key markers including RUNX2, OPN, and BMP2. Mechanistically, EV-derived miRNAs, notably miR-146a-5p, were associated with activation of the Sirt1/Wnt/β-catenin signaling pathway. In a rat critical-size calvarial defect model, CS-EVs/DC-FS accelerated bone deposition, improved trabecular microstructure, and enhanced overall regeneration quality. This study establishes a topography-guided and EV-mediated strategy for bone regeneration, offering an integrated nature-derived solution for reconstructing challenging maxillofacial and orthopedic bone defects.
- 7 November 2022
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 14 (45) , 50626-50636
“All-in-One” Exosome Engineering Strategy for Effective Therapy of Familial Hypercholesterolemia
Exosomes serve as a promising therapeutic nanoplatform. However, the exosomes produced by donor cells are a heterogeneous group, with only a small portion having high therapeutic efficacy. Specific isolation of the subpopulation with high efficacy is important for lowering the dose and minimizing toxicity. In this study, we loaded target mRNA and displayed specific Flag in engineered exosomes simultaneously. Briefly, the donor cells were transfected with plasmid expressing a fusion protein Flag-TCS-PTGFRN-CTSL-MCP, namely, exosome sorter. During biogenesis, the RNA-binding motif MCP can specifically bind with MS2-containing RNA and sort the target RNA into the lumen of exosomes. Anti-Flag magnetic beads can capture and thus purify the engineered exosomes via recognition of the Flag on the surface of exosomes. After purification, the Flag could be cleaved by thrombin treatment while MCP can be separated from the fusion protein by CTSL autocleavage upon exosome acidification, minimizing the side effects and augmenting the therapeutic effects. By the proof-of-concept experiment, the exosome sorter-based "all-in-one" strategy was confirmed effective in both the encapsulation of therapeutic mRNA (Ldlr-MS2) into exosomes and the subsequent purification. The purified Ldlr-MS2-containing exosomes had much higher efficacy in alleviating atherosclerosis, in comparison with the bulk exosomes, confirming the advantage of the proposed "all-in-one" strategy.
- 7 November 2022
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 14 (45) , 50626-50636
“All-in-One” Exosome Engineering Strategy for Effective Therapy of Familial Hypercholesterolemia
Exosomes serve as a promising therapeutic nanoplatform. However, the exosomes produced by donor cells are a heterogeneous group, with only a small portion having high therapeutic efficacy. Specific isolation of the subpopulation with high efficacy is important for lowering the dose and minimizing toxicity. In this study, we loaded target mRNA and displayed specific Flag in engineered exosomes simultaneously. Briefly, the donor cells were transfected with plasmid expressing a fusion protein Flag-TCS-PTGFRN-CTSL-MCP, namely, exosome sorter. During biogenesis, the RNA-binding motif MCP can specifically bind with MS2-containing RNA and sort the target RNA into the lumen of exosomes. Anti-Flag magnetic beads can capture and thus purify the engineered exosomes via recognition of the Flag on the surface of exosomes. After purification, the Flag could be cleaved by thrombin treatment while MCP can be separated from the fusion protein by CTSL autocleavage upon exosome acidification, minimizing the side effects and augmenting the therapeutic effects. By the proof-of-concept experiment, the exosome sorter-based "all-in-one" strategy was confirmed effective in both the encapsulation of therapeutic mRNA (Ldlr-MS2) into exosomes and the subsequent purification. The purified Ldlr-MS2-containing exosomes had much higher efficacy in alleviating atherosclerosis, in comparison with the bulk exosomes, confirming the advantage of the proposed "all-in-one" strategy.
- Open Access
- 19 October 2021
- Published by Elsevier in Molecular Therapy Nucleic Acids
- Vol. 26, 987-996
Smart exosomes with lymph node homing and immune-amplifying capacities for enhanced immunotherapy of metastatic breast cancer
- 19 October 2021
- Published by Elsevier in Molecular Therapy Nucleic Acids
- Vol. 26, 987-996
Open AccessSmart exosomes with lymph node homing and immune-amplifying capacities for enhanced immunotherapy of metastatic breast cancer
- 14 October 2021
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 21 (20) , 8563-8570
Selective Encapsulation of Therapeutic mRNA in Engineered Extracellular Vesicles by DNA Aptamer
Extracellular vesicles (EV)-based delivery of therapeutic mRNAs is challenged by the low loading efficiency. In this study, we designed a DNA aptamer consisting of two parts: the single strand part recognized the AUG region of target mRNA, preventing mRNA from translation and ribosome assembly; and the double strand part containing the elements recognized by the CD9-ZF (zinc finger) motifs, sorting DNA aptamer-mRNA complex into CD9-ZF engineered EVs. In vitro and in vivo studies revealed that the system could efficiently load functional mRNAs to the EVs. Furthermore, adipose specific delivery of loaded Pgc1α mRNA via the strategy could efficiently induce white adipocyte browning. Similarly, delivery of interleukin-10 (Il-10) mRNA via the strategy had potent anti-inflammatory effect in inflammatory bowel disease (IBD) mouse model. Together, our study has proposed an efficient strategy to load therapeutic mRNAs of interest into EVs, which could be used as a promising strategy for gene therapy.
- 14 October 2021
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 21 (20) , 8563-8570
Selective Encapsulation of Therapeutic mRNA in Engineered Extracellular Vesicles by DNA Aptamer
Extracellular vesicles (EV)-based delivery of therapeutic mRNAs is challenged by the low loading efficiency. In this study, we designed a DNA aptamer consisting of two parts: the single strand part recognized the AUG region of target mRNA, preventing mRNA from translation and ribosome assembly; and the double strand part containing the elements recognized by the CD9-ZF (zinc finger) motifs, sorting DNA aptamer-mRNA complex into CD9-ZF engineered EVs. In vitro and in vivo studies revealed that the system could efficiently load functional mRNAs to the EVs. Furthermore, adipose specific delivery of loaded Pgc1α mRNA via the strategy could efficiently induce white adipocyte browning. Similarly, delivery of interleukin-10 (Il-10) mRNA via the strategy had potent anti-inflammatory effect in inflammatory bowel disease (IBD) mouse model. Together, our study has proposed an efficient strategy to load therapeutic mRNAs of interest into EVs, which could be used as a promising strategy for gene therapy.
- 10 April 2020
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 14 (4) , 5099-5110
Visceral Adipose Tissue Derived Exosomes Exacerbate Colitis Severity via Pro-inflammatory MiRNAs in High Fat Diet Fed Mice
A pioneering epidemic study has revealed a strong association between obesity and the risk of colitis. In this study, a high fat diet was found to significantly aggravate colitis induced by dextran sulfate sodium (DSS). Meanwhile, a high fat diet changed the miRNA profile of the visceral adipose exosomes, switching the exosomes from anti-inflammatory to a pro-inflammatory phenotype. Strikingly, these inflammatory exosomes efficiently circulated into the lamina propria of the intestine, while these exosomes predisposed the intestine to inflammation via promoting macrophage M1 polarization. Mechanistically, the exosomes promoted M1 differentiation at least partially via transferring pro-inflammatory miRNAs, such as miR-155. Moreover, exosome-mediated miR-155 inhibitor delivery significantly prevented DSS-induced colitis. Together, the study has revealed an exosomal pathway of how obesity aggravates colitis and proposes an exosome-based intervention strategy for colitis management.
- 10 April 2020
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 14 (4) , 5099-5110
Visceral Adipose Tissue Derived Exosomes Exacerbate Colitis Severity via Pro-inflammatory MiRNAs in High Fat Diet Fed Mice
A pioneering epidemic study has revealed a strong association between obesity and the risk of colitis. In this study, a high fat diet was found to significantly aggravate colitis induced by dextran sulfate sodium (DSS). Meanwhile, a high fat diet changed the miRNA profile of the visceral adipose exosomes, switching the exosomes from anti-inflammatory to a pro-inflammatory phenotype. Strikingly, these inflammatory exosomes efficiently circulated into the lamina propria of the intestine, while these exosomes predisposed the intestine to inflammation via promoting macrophage M1 polarization. Mechanistically, the exosomes promoted M1 differentiation at least partially via transferring pro-inflammatory miRNAs, such as miR-155. Moreover, exosome-mediated miR-155 inhibitor delivery significantly prevented DSS-induced colitis. Together, the study has revealed an exosomal pathway of how obesity aggravates colitis and proposes an exosome-based intervention strategy for colitis management.